抑制ADP-ribosylation逆转会触发细胞对化剂的脆弱性
Rocco Caggiano1, Evgeniia Prokhorova2, Lena Duma2
1Institute of Experimental Endocrinology and Oncology, National Research Council of Italy, Naples, Italy.
Neoplasia (New York, N.Y.)
|November 30, 2024
概括
与DNA化剂一起向PARG和ARH3等ADP-ribosyl化酶显示出癌症治疗的前景. 这种组合通过损害DNA修复机制来增强细胞死亡.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- ADP-ribosylation 是一个关键的翻译后修饰,由多分子ADP-ribose聚合酶 (PARP) 调节.
- 包括PARG和ARH3在内的ADP-ribosyl酸酶逆转PARP活性,它们的联合抑制表现出合成杀伤性.
- 这种合成杀伤性的精确分子基础及其与DNA损伤的相互作用仍然不清楚.
研究的目的:
- 阐明PARG和ARH3.3合成致死性的基础分子机制.
- 研究PARG和ARH3联合抑制对DNA修复的影响,特别是在DNA化剂的背景下.
- 探索在癌症治疗中准这些酶的治疗潜力.
主要方法:
- 使用ARH3淘汰细胞系和PARG抑制剂.
- 用DNA化基因毒素处理的细胞.
- 评估了DNA损伤,单链DNA积累,细胞周期进展 (G2/M停止),细胞亡以及PARP1/PARP2蛋白水平.
主要成果:
- PARG和ARH3的合成致死性被DNA化剂加剧,这表明它在修复化DNA基中的作用.
- 用PARG抑制剂和基因毒素治疗的ARH3缺乏细胞显示DNA损伤增加和G2/M停止,导致细胞亡.
- 用PARG抑制剂治疗ARH3缺乏细胞中的过度ADP-ribosylation导致PARP1/PARP2水平的降低,从而增加对化剂的敏感性.
结论:
- 无法去除ADP-ribosylation严重损害了基化DNA基的修复.
- 向PARG和ARH3与基化剂一起,为癌症治疗提供了一个潜在的战略.
- 这项研究提供了对PARG和ARH3之间的合成致命相互作用及其对DNA损伤反应的影响的机制性见解.
关键词:
在ADP-ribosyl酸盐酸酶中.在ADP-ribosylation过程中.ARH3ARH3ARH3ARH3ARH3ARH3ARH3ARH3ARH3ARH3ARH3ARH3ARH3ARH3ARH3化剂药物是一种化药物.癌症 癌症 癌症 癌症造成的DNA损伤是DNA损伤.这是一种PARG抑制剂.这是一种PARP抑制剂.更多相关视频
12:28Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
7.3K
06:44Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
3.9K
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:37DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
01:23Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
01:28Biosynthesis of Nucleic Acids
7
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
7
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K